ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
  Sardana K, Sinha S, Bhushan P , 2020. Reactions in leprosy. Sardana K, Khurana A, eds. Jopling’s Handbook of Leprosy, 6th edition. New Delhi, India: CBS, 192–194.
-
2.
  Khurana A, Sardana K , 2020. Immunopathogenesis of reactions. Sardana K, Khurana A, eds. Jopling’s Handbook of Leprosy, 6th edition. New Delhi, India: CBS, 182–186.
-
3.
  Ridley DS, Radia KB , 1981. The histological course of reactions in borderline leprosy and their outcome. Int J Lepr Other Mycobact Dis 49: 383–392.
-
4.
  Sinha S, Sardana K, Agrawal D, Malhotra P, Lavania M, Ahuja M , 2019. Multidrug resistance as a cause of steroid nonresponsive downgrading type 1 reaction in Hansen’s disease. Int J Mycobacteriol 8: 305–308.
-
5.
  Costa MB et al.2018. In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions. PLoS One 13: e0196853.
-
6.
  Saini C, Siddiqui A, Ramesh V, Nath I , 2016. Leprosy reactions show increased Th17 cell activity and reduced FoxP3+ Tregs with concomitant decrease in TGF-β and increase in IL-6. PLoS Negl Trop Dis 10: e0004592.
-
7.
  Zheng H, Zeltsman M, Zauderer MG, Eguchi T, Vaghjiani RG, Adusumilli PS , 2017. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy. Immunotherapy 9: 913–927.
-
8.
  Zhang L et al.2008. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy. Clin Immunol (Orlando, FL) 129: 219–229.
-
9.
  Roselli M et al.2013. Effects of conventional therapeutic interventions on the number and function of regulatory T cells. OncoImmunology 2: e27025.
-
10.
  Siva S, MacManus MP, Martin RF, Martin OA , 2015. Abscopal effects of radiation therapy: a clinical review for the radiobiologist. Cancer Lett 356: 82–90.
-
11.
  Massone C et al.2011. Leprosy and HIV coinfection: a critical approach. Expert Rev Anti Infect Ther 9: 701–710.
-
12.
  Scollard DM, Joyce MP, Gillis TP , 2006. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases. Clin Infect Dis 43: e19–e22.
-
13.
  Grossman D, Rapini RP, Osborne B, Duvic M , 1994. Emergence of leprosy in a patient with mycosis fungoides. J Am Acad Dermatol 30: 313–315.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 2875 | 2875 | 201 |
| Full Text Views | 41 | 41 | 0 |
| PDF Downloads | 58 | 58 | 0 |
.png)
Case Report: Chemoradiation with Paclitaxel and Carboplatin Unveiling Leprosy Type 1 Downgrading Reaction
ABSTRACT.
Type 1 lepra reaction (T1R) is a major complication seen in nonpolar forms of leprosy and leads to significant morbidity. The classification of T1R as up and downgrading, based on previously defined histopathological criteria (by Ridley), has therapeutic and prognostic implications. The trigger factors for these reactions are poorly described, especially in case of downgrading T1R and we describe a case of leprosy reaction that was possibly triggered by chemoradiation and elucidate the possible mechanism.
Author Notes
Data availability statement: Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Ethics statement: We declare that the research was conducted in compliance with the declaration of Helsinki.
Authors’ addresses: B. Savitha, Kabir Sardana, Ananta Khurana, Seema Rani, and Soumya Sachdeva, Department of Dermatology, Dr. Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India, E-mails: savitharavivarma@gmail.com, kabirijdvl@gmail.com, drananta2014@gmail.com, drseemashekhar@gmail.com, soumyasachdeva1402@gmail.com. Arvind Ahuja, Department of Pathology, Dr. Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, E-mail: drarvindahuja@gmail.com.